Cardinal Health 414, LLC

Cardinal Health 414, LLC (United States) holds 4 active US FDA Type II Drug Master Files and 5 inactive and is linked to 1 FDA-registered manufacturing site. 50 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Cardinal Health 414, LLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/cardinal-health-414-llc

Overview

Cardinal Health 414, LLC is a subsidiary of Cardinal Health, Inc., a global healthcare services and products company. The company focuses on providing pharmaceutical and medical products and services to various healthcare providers, enhancing healthcare efficiency and outcomes.

Therapeutic areas

Pharmaceutical DistributionMedical Products

API / Drug Master Files

Cardinal Health 414, LLC holds 4 active (9 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • ZIRCONIUM ZR-89 OXALATE SOLUTIONActive2026-05-29
  • ACTINIUM (225AC) NITRATE SOLUTIONActive2024-12-19
  • GALLIUM GA-68 CHLORIDE SOLUTIONActive2024-04-18
  • TETRAKIS (2-METHOXYISOBUTYLISONITRILE) COPPER (I) TETRAFLUOROBORATE DRUG SUBSTANCEActive2006-12-22
  • SODIUM ACETATE C-11 INJECTIONInactive2011-01-19
  • FLUOROMISONIDAZOLE F18 INJECTION([18F]FMISO)Inactive2009-06-16
  • 3-DEOXY-3-[18F]FLUOROTHYMIDINE ([18F]FLT)Inactive2009-04-03
  • SODIUM FLUORIDE F18 INJECTIONInactive2008-08-29
  • FLUOROMISONIDAZOLE F 18 INJECTIONInactive2008-06-12

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Cardinal Health 414, LLC, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

50 FDA enforcement records linked to this company.

  • 4832026-04-03

    Equipment procedures

  • 4832026-03-18

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832026-02-06

    Correction of problems

  • 4832026-02-06

    Written QA procedures established, followed

  • 4832026-02-06

    Non-Conforming Product Investigation Incomplete

  • 4832026-02-06

    Complaint record contents

  • 4832026-01-23

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832026-01-23

    Equipment procedures

  • 4832025-09-12

    Investigations of discrepancies, failures

  • 4832025-09-12

    Cleaning / Sanitizing / Maintenance

  • 4832025-09-12

    In-process samples representative, identified properly

  • 4832025-08-28

    Specifications and processes

  • 4832025-07-31

    Written QA procedures established, followed

  • 4832025-07-31

    Documentation of Non-Conforming Product Investigation

  • 4832025-07-31

    Correction of problems

  • 4832025-07-31

    Lack of disinfection, equipment/supplies from lower to higher quality air

  • 4832025-07-31

    Personnel, blocked or disrupted first air

  • 4832025-07-01

    Lab written procedures

  • 4832025-07-01

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832025-07-01

    Correction of problems

  • 4832025-07-01

    Adequate controls (general)

  • 4832025-06-13

    Written QA procedures established, followed

  • 4832024-09-25

    Written QA procedures established, followed

  • 4832024-09-25

    Stability testing program

  • 4832024-09-24

    Adequate controls (general)

  • 4832024-01-09

    Written QA procedures established, followed

  • 4832021-03-18

    Adequate controls (general)

  • 4832020-02-25

    Determination need for investigation

  • 4832020-02-25

    Adequate controls (general)

  • 4832020-02-25

    Written QA procedures established, followed

  • 4832019-06-18

    Supplies adequately controlled

  • 4832018-11-08

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832018-10-26

    Equipment procedures

  • 4832018-10-26

    Conform to specs prior to release

  • 4832018-10-26

    Written QA procedures established, followed

  • 4832018-10-26

    Correction of problems

  • 4832018-10-26

    Documentation of Non-Conforming Product Investigation

  • 4832018-08-23

    Review of records for errors

  • 4832018-08-23

    Written QA procedures established, followed

  • 4832018-08-03

    Equipment procedures

  • 4832018-08-03

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832018-04-20

    Written QA procedures established, followed

  • 4832018-03-16

    Written QA procedures established, followed

  • 4832018-01-25

    Determination need for investigation

  • 4832018-01-25

    Adequate controls (general)

  • 4832018-01-25

    Analytical methods

  • 4832018-01-25

    Personnel not qualified

  • 4832015-11-12

    Conform to specs prior to release

  • 4832015-10-16

    Written QA procedures established, followed

  • 4832015-10-16

    Sub-batches

For suppliers

Is this Cardinal Health 414, LLC?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.